BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24282088)

  • 1. Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites.
    Fang N; Zhang HQ; He B; Xie M; Lu S; Wan YY; Wang NR
    Tumour Biol; 2014 Apr; 35(4):3261-8. PubMed ID: 24282088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinicopathological characteristics of gastric cancer in adolescents aged 10-24 years: 17-year experience of 17 years in a single institute].
    Zhang W; Liang WQ; Cai AZ; Wang PP; Xi HQ; Liu GX; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Oct; 23(10):963-968. PubMed ID: 33053991
    [No Abstract]   [Full Text] [Related]  

  • 3. Pattern and prognostic factors in patients with malignant ascites: a retrospective study.
    Ayantunde AA; Parsons SL
    Ann Oncol; 2007 May; 18(5):945-9. PubMed ID: 17298959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.
    Ba MC; Long H; Zhang XL; Gong YF; Tang YQ; Wu YB; Yu FH; Cui SZ
    J Laparoendosc Adv Surg Tech A; 2016 Jan; 26(1):32-9. PubMed ID: 26779722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of the prognosis of 111 patients with gastric cancer or adenocarcinoma of the esophagogastric junction combined with pleural or abdominal effusion].
    Liu Y; Du CX; Zhang HG
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):693-7. PubMed ID: 24332058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric cancer patients with Helicobacter pylori infection have a poor prognosis.
    Li G; Wang Z; Wang Z; Xu J; Cui J; Cai S; Zhan W; He Y
    J Surg Oncol; 2013 Dec; 108(7):421-6. PubMed ID: 24037736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensifying supportive care is associated with improved survival in gastric cancer patients with malignant ascites.
    Karalis JD; Ju MR; Feig R; Estrella R; Pettigrew MF; Alterio RE; Abreu AA; Farah E; Sawas T; Sanford NN; Sanjeevaiah A; Hammer STG; Porembka MR; Wang SC
    J Surg Oncol; 2024 Mar; 129(4):718-727. PubMed ID: 38063245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical efficacy of type-B ultrasound-guided intraperitoneal hyperthermic chemoperfusion combined with systemic chemotherapy in advanced gastric cancer patients with malignant ascites.
    Lu C; Li L; Luo Z; Cui Y; Fu P; Zhou J; Ma N; Zhou Y
    Neoplasma; 2016; 63(2):299-303. PubMed ID: 26774152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
    DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
    Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
    Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
    Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
    Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
    Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of the neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio in patients with metastatic gastric cancer.
    Zhao G; Liu N; Wang S; Guo J; Song X; Qi Y; Qiu W; Lv J
    Medicine (Baltimore); 2020 Mar; 99(10):e19405. PubMed ID: 32150090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MELD-sodium score and its prognostic value in malignancy-related ascites of pancreatic and gastric cancer.
    Engin H; Bilir C; Ustündağ Y
    Support Care Cancer; 2013 Apr; 21(4):1153-6. PubMed ID: 23104454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics of Helicobacter pyloric seropositive gastric adenocarcinomas.
    Lee WJ; Lin JT; Lee WC; Shun CT; Hong RL; Cheng AL; Lee PH; Wei TC; Chen KM
    J Clin Gastroenterol; 1995 Oct; 21(3):203-7. PubMed ID: 8648053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Surgical treatment and prognosis of Borrmann type IIII( gastric cancer involving the whole stomach].
    Dong R; Zhang Z; Zhou Y; Hua Y; Guo J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):185-189. PubMed ID: 29492918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
    Song S; Liu H; Xue Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.
    Liu DJ; Fu XL; Liu W; Zheng LY; Zhang JF; Huo YM; Li J; Hua R; Liu Q; Sun YW
    World J Gastroenterol; 2017 Jan; 23(3):516-524. PubMed ID: 28210088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weekly paclitaxel as second-line chemotherapy in Japanese patients with advanced gastric cancer.
    Kadokura M; Iwasa S; Honma Y; Kato K; Hamaguchi T; Yamada Y; Enomoto N; Shimada Y
    Anticancer Res; 2013 Oct; 33(10):4547-52. PubMed ID: 24123029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.